The IBA Healthcare and Life Sciences Law Committee has put together a legal guide that comprises a global review of major topics and trends concerning the trade and distribution of therapeutic products, including pharmaceuticals/biologics and medical devices, across more than 50 countries.

The Ireland section provides an overview of the regulatory framework and competent authorities and includes a description of product classification, licensing and authorisation requirements for wholesale and retail distribution, import and export controls, labelling, serialisation and anti-counterfeiting requirements, pricing and reimbursement requirements, enforcement powers and sanctions, as well as recent developments and trends.

Members of our Life Sciences Group who authored the Ireland section of the 2026 survey include: Colin Kavanagh (Partner), Orla Clayton (Of Counsel), Bridget Clinton (Senior Associate) and associates Robert Byrne, Aoibhín Ní Dhubháin and Aoife O’Malley.

To read the full survey, please visit the International Bar Association’s website.